Global Next Generation Cancer Diagnostic Devices Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Next Generation Cancer Diagnostic Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Next Generation Cancer Diagnostic Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Next Generation Cancer Diagnostic Devices by Country/Region, 2017, 2022 & 2028

2.2 Next Generation Cancer Diagnostic Devices Segment by Type

2.2.1 Next Generation Sequencing

2.2.2 qPCR & Multiplexing

2.2.3 Lab-on- a- chip (LOAC)

2.2.4 Protein Microarrays

2.2.5 DNA Microarrays

2.2.6 Reverse Transcriptase-PCR (RT-PCR)

2.3 Next Generation Cancer Diagnostic Devices Sales by Type

2.3.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Next Generation Cancer Diagnostic Devices Sale Price by Type (2017-2022)

2.4 Next Generation Cancer Diagnostic Devices Segment by Application

2.4.1 Biomarker Development

2.4.2 CTC Analysis

2.4.3 Proteomic Analysis

2.4.4 Epigenetic Analysis

2.4.5 Genetic Analysis

2.5 Next Generation Cancer Diagnostic Devices Sales by Application

2.5.1 Global Next Generation Cancer Diagnostic Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Next Generation Cancer Diagnostic Devices Sale Price by Application (2017-2022)

3 Global Next Generation Cancer Diagnostic Devices by Company

3.1 Global Next Generation Cancer Diagnostic Devices Breakdown Data by Company

3.1.1 Global Next Generation Cancer Diagnostic Devices Annual Sales by Company (2020-2022)

3.1.2 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2020-2022)

3.2 Global Next Generation Cancer Diagnostic Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Next Generation Cancer Diagnostic Devices Revenue by Company (2020-2022)

3.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2020-2022)

3.3 Global Next Generation Cancer Diagnostic Devices Sale Price by Company

3.4 Key Manufacturers Next Generation Cancer Diagnostic Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Next Generation Cancer Diagnostic Devices Product Location Distribution

3.4.2 Players Next Generation Cancer Diagnostic Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Next Generation Cancer Diagnostic Devices by Geographic Region

4.1 World Historic Next Generation Cancer Diagnostic Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Next Generation Cancer Diagnostic Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Next Generation Cancer Diagnostic Devices Annual Revenue by Geographic Region

4.2 World Historic Next Generation Cancer Diagnostic Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Next Generation Cancer Diagnostic Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Next Generation Cancer Diagnostic Devices Annual Revenue by Country/Region

4.3 Americas Next Generation Cancer Diagnostic Devices Sales Growth

4.4 APAC Next Generation Cancer Diagnostic Devices Sales Growth

4.5 Europe Next Generation Cancer Diagnostic Devices Sales Growth

4.6 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Growth

5 Americas

5.1 Americas Next Generation Cancer Diagnostic Devices Sales by Country

5.1.1 Americas Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022)

5.1.2 Americas Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022)

5.2 Americas Next Generation Cancer Diagnostic Devices Sales by Type

5.3 Americas Next Generation Cancer Diagnostic Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Next Generation Cancer Diagnostic Devices Sales by Region

6.1.1 APAC Next Generation Cancer Diagnostic Devices Sales by Region (2017-2022)

6.1.2 APAC Next Generation Cancer Diagnostic Devices Revenue by Region (2017-2022)

6.2 APAC Next Generation Cancer Diagnostic Devices Sales by Type

6.3 APAC Next Generation Cancer Diagnostic Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Next Generation Cancer Diagnostic Devices by Country

7.1.1 Europe Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022)

7.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022)

7.2 Europe Next Generation Cancer Diagnostic Devices Sales by Type

7.3 Europe Next Generation Cancer Diagnostic Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Next Generation Cancer Diagnostic Devices by Country

8.1.1 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Type

8.3 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices

10.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices

10.4 Industry Chain Structure of Next Generation Cancer Diagnostic Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Next Generation Cancer Diagnostic Devices Distributors

11.3 Next Generation Cancer Diagnostic Devices Customer

12 World Forecast Review for Next Generation Cancer Diagnostic Devices by Geographic Region

12.1 Global Next Generation Cancer Diagnostic Devices Market Size Forecast by Region

12.1.1 Global Next Generation Cancer Diagnostic Devices Forecast by Region (2023-2028)

12.1.2 Global Next Generation Cancer Diagnostic Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Next Generation Cancer Diagnostic Devices Forecast by Type

12.7 Global Next Generation Cancer Diagnostic Devices Forecast by Application

13 Key Players Analysis

13.1 Roche Holding Ltd.（Switzerland)

13.1.1 Roche Holding Ltd.（Switzerland) Company Information

13.1.2 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product Offered

13.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Holding Ltd.（Switzerland) Main Business Overview

13.1.5 Roche Holding Ltd.（Switzerland) Latest Developments

13.2 Abbott Laboratories(US)

13.2.1 Abbott Laboratories(US) Company Information

13.2.2 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Offered

13.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Abbott Laboratories(US) Main Business Overview

13.2.5 Abbott Laboratories(US) Latest Developments

13.3 Siemens Healthcare(Germany)

13.3.1 Siemens Healthcare(Germany) Company Information

13.3.2 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Offered

13.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Siemens Healthcare(Germany) Main Business Overview

13.3.5 Siemens Healthcare(Germany) Latest Developments

13.4 Agilent Technologies Inc(Germany)

13.4.1 Agilent Technologies Inc(Germany) Company Information

13.4.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Offered

13.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Agilent Technologies Inc(Germany) Main Business Overview

13.4.5 Agilent Technologies Inc(Germany) Latest Developments

13.5 Illumina Inc.(US)

13.5.1 Illumina Inc.(US) Company Information

13.5.2 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Illumina Inc.(US) Main Business Overview

13.5.5 Illumina Inc.(US) Latest Developments

13.6 Becton Dickinson and Co.(US)

13.6.1 Becton Dickinson and Co.(US) Company Information

13.6.2 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Becton Dickinson and Co.(US) Main Business Overview

13.6.5 Becton Dickinson and Co.(US) Latest Developments

13.7 QIAGEN N.V.(Germany)

13.7.1 QIAGEN N.V.(Germany) Company Information

13.7.2 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Offered

13.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 QIAGEN N.V.(Germany) Main Business Overview

13.7.5 QIAGEN N.V.(Germany) Latest Developments

13.8 Affymetrix Inc.(US)

13.8.1 Affymetrix Inc.(US) Company Information

13.8.2 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Affymetrix Inc.(US) Main Business Overview

13.8.5 Affymetrix Inc.(US) Latest Developments

13.9 Johnson & Johnson(US)

13.9.1 Johnson & Johnson(US) Company Information

13.9.2 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Offered

13.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Johnson & Johnson(US) Main Business Overview

13.9.5 Johnson & Johnson(US) Latest Developments

13.10 Thermo Fisher Scientific Inc.(US)

13.10.1 Thermo Fisher Scientific Inc.(US) Company Information

13.10.2 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Thermo Fisher Scientific Inc.(US) Main Business Overview

13.10.5 Thermo Fisher Scientific Inc.(US) Latest Developments

13.11 GE Healthcare(England)

13.11.1 GE Healthcare(England) Company Information

13.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Offered

13.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 GE Healthcare(England) Main Business Overview

13.11.5 GE Healthcare(England) Latest Developments

13.12 Life Technologies Corp.(US)

13.12.1 Life Technologies Corp.(US) Company Information

13.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Life Technologies Corp.(US) Main Business Overview

13.12.5 Life Technologies Corp.(US) Latest Developments

13.13 Luminex Corp.(US)

13.13.1 Luminex Corp.(US) Company Information

13.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Luminex Corp.(US) Main Business Overview

13.13.5 Luminex Corp.(US) Latest Developments

13.14 Cepheid Inc.(US)

13.14.1 Cepheid Inc.(US) Company Information

13.14.2 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

13.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Cepheid Inc.(US) Main Business Overview

13.14.5 Cepheid Inc.(US) Latest Developments

13.15 Allegro Diagnostics Corp.(Brazil)

13.15.1 Allegro Diagnostics Corp.(Brazil) Company Information

13.15.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Offered

13.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Allegro Diagnostics Corp.(Brazil) Main Business Overview

13.15.5 Allegro Diagnostics Corp.(Brazil) Latest Developments

14 Research Findings and Conclusion

Table 1. Next Generation Cancer Diagnostic Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Next Generation Cancer Diagnostic Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Next Generation Sequencing

Table 4. Major Players of qPCR & Multiplexing

Table 5. Major Players of Lab-on- a- chip (LOAC)

Table 6. Major Players of Protein Microarrays

Table 7. Major Players of DNA Microarrays

Table 8. Major Players of Reverse Transcriptase-PCR (RT-PCR)

Table 9. Global Next Generation Cancer Diagnostic Devices Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)

Table 11. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2022) & ($ million)

Table 12. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2017-2022)

Table 13. Global Next Generation Cancer Diagnostic Devices Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Next Generation Cancer Diagnostic Devices Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)

Table 16. Global Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2022)

Table 17. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2017-2022)

Table 18. Global Next Generation Cancer Diagnostic Devices Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Next Generation Cancer Diagnostic Devices Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2020-2022)

Table 21. Global Next Generation Cancer Diagnostic Devices Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2020-2022)

Table 23. Global Next Generation Cancer Diagnostic Devices Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Next Generation Cancer Diagnostic Devices Producing Area Distribution and Sales Area

Table 25. Players Next Generation Cancer Diagnostic Devices Products Offered

Table 26. Next Generation Cancer Diagnostic Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Next Generation Cancer Diagnostic Devices Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Next Generation Cancer Diagnostic Devices Sales Market Share Geographic Region (2017-2022)

Table 31. Global Next Generation Cancer Diagnostic Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Next Generation Cancer Diagnostic Devices Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Country/Region (2017-2022)

Table 35. Global Next Generation Cancer Diagnostic Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)

Table 39. Americas Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)

Table 41. Americas Next Generation Cancer Diagnostic Devices Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)

Table 43. Americas Next Generation Cancer Diagnostic Devices Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)

Table 45. APAC Next Generation Cancer Diagnostic Devices Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2017-2022)

Table 47. APAC Next Generation Cancer Diagnostic Devices Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2017-2022)

Table 49. APAC Next Generation Cancer Diagnostic Devices Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)

Table 51. APAC Next Generation Cancer Diagnostic Devices Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)

Table 53. Europe Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)

Table 55. Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)

Table 57. Europe Next Generation Cancer Diagnostic Devices Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)

Table 59. Europe Next Generation Cancer Diagnostic Devices Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Next Generation Cancer Diagnostic Devices

Table 70. Key Market Challenges & Risks of Next Generation Cancer Diagnostic Devices

Table 71. Key Industry Trends of Next Generation Cancer Diagnostic Devices

Table 72. Next Generation Cancer Diagnostic Devices Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Next Generation Cancer Diagnostic Devices Distributors List

Table 75. Next Generation Cancer Diagnostic Devices Customer List

Table 76. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Next Generation Cancer Diagnostic Devices Sales Market Forecast by Region

Table 78. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Next Generation Cancer Diagnostic Devices Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Next Generation Cancer Diagnostic Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Next Generation Cancer Diagnostic Devices Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Next Generation Cancer Diagnostic Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Application (2023-2028)

Table 96. Roche Holding Ltd.（Switzerland) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 97. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product Offered

Table 98. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Roche Holding Ltd.（Switzerland) Main Business

Table 100. Roche Holding Ltd.（Switzerland) Latest Developments

Table 101. Abbott Laboratories(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 102. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 103. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Abbott Laboratories(US) Main Business

Table 105. Abbott Laboratories(US) Latest Developments

Table 106. Siemens Healthcare(Germany) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 107. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Offered

Table 108. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Siemens Healthcare(Germany) Main Business

Table 110. Siemens Healthcare(Germany) Latest Developments

Table 111. Agilent Technologies Inc(Germany) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 112. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Offered

Table 113. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Agilent Technologies Inc(Germany) Main Business

Table 115. Agilent Technologies Inc(Germany) Latest Developments

Table 116. Illumina Inc.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 117. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 118. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Illumina Inc.(US) Main Business

Table 120. Illumina Inc.(US) Latest Developments

Table 121. Becton Dickinson and Co.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 122. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 123. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Becton Dickinson and Co.(US) Main Business

Table 125. Becton Dickinson and Co.(US) Latest Developments

Table 126. QIAGEN N.V.(Germany) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 127. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Offered

Table 128. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. QIAGEN N.V.(Germany) Main Business

Table 130. QIAGEN N.V.(Germany) Latest Developments

Table 131. Affymetrix Inc.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 132. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 133. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Affymetrix Inc.(US) Main Business

Table 135. Affymetrix Inc.(US) Latest Developments

Table 136. Johnson & Johnson(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 137. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 138. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Johnson & Johnson(US) Main Business

Table 140. Johnson & Johnson(US) Latest Developments

Table 141. Thermo Fisher Scientific Inc.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 142. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 143. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Thermo Fisher Scientific Inc.(US) Main Business

Table 145. Thermo Fisher Scientific Inc.(US) Latest Developments

Table 146. GE Healthcare(England) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 147. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Offered

Table 148. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. GE Healthcare(England) Main Business

Table 150. GE Healthcare(England) Latest Developments

Table 151. Life Technologies Corp.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 152. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 153. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. Life Technologies Corp.(US) Main Business

Table 155. Life Technologies Corp.(US) Latest Developments

Table 156. Luminex Corp.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 157. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 158. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 159. Luminex Corp.(US) Main Business

Table 160. Luminex Corp.(US) Latest Developments

Table 161. Cepheid Inc.(US) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 162. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Offered

Table 163. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 164. Cepheid Inc.(US) Main Business

Table 165. Cepheid Inc.(US) Latest Developments

Table 166. Allegro Diagnostics Corp.(Brazil) Basic Information, Next Generation Cancer Diagnostic Devices Manufacturing Base, Sales Area and Its Competitors

Table 167. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Offered

Table 168. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 169. Allegro Diagnostics Corp.(Brazil) Main Business

Table 170. Allegro Diagnostics Corp.(Brazil) Latest Developments

List of Figures

Figure 1. Picture of Next Generation Cancer Diagnostic Devices

Figure 2. Next Generation Cancer Diagnostic Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Next Generation Cancer Diagnostic Devices Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Next Generation Cancer Diagnostic Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Next Generation Cancer Diagnostic Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Next Generation Sequencing

Figure 10. Product Picture of qPCR & Multiplexing

Figure 11. Product Picture of Lab-on- a- chip (LOAC)

Figure 12. Product Picture of Protein Microarrays

Figure 13. Product Picture of DNA Microarrays

Figure 14. Product Picture of Reverse Transcriptase-PCR (RT-PCR)

Figure 15. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2021

Figure 16. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2017-2022)

Figure 17. Next Generation Cancer Diagnostic Devices Consumed in Biomarker Development

Figure 18. Global Next Generation Cancer Diagnostic Devices Market: Biomarker Development (2017-2022) & (K Pcs)

Figure 19. Next Generation Cancer Diagnostic Devices Consumed in CTC Analysis

Figure 20. Global Next Generation Cancer Diagnostic Devices Market: CTC Analysis (2017-2022) & (K Pcs)

Figure 21. Next Generation Cancer Diagnostic Devices Consumed in Proteomic Analysis

Figure 22. Global Next Generation Cancer Diagnostic Devices Market: Proteomic Analysis (2017-2022) & (K Pcs)

Figure 23. Next Generation Cancer Diagnostic Devices Consumed in Epigenetic Analysis

Figure 24. Global Next Generation Cancer Diagnostic Devices Market: Epigenetic Analysis (2017-2022) & (K Pcs)

Figure 25. Next Generation Cancer Diagnostic Devices Consumed in Genetic Analysis

Figure 26. Global Next Generation Cancer Diagnostic Devices Market: Genetic Analysis (2017-2022) & (K Pcs)

Figure 27. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2022)

Figure 28. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application in 2021

Figure 29. Next Generation Cancer Diagnostic Devices Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Company in 2021

Figure 31. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Geographic Region in 2021

Figure 33. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2017-2022)

Figure 34. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Country/Region in 2021

Figure 35. Americas Next Generation Cancer Diagnostic Devices Sales 2017-2022 (K Pcs)

Figure 36. Americas Next Generation Cancer Diagnostic Devices Revenue 2017-2022 ($ Millions)

Figure 37. APAC Next Generation Cancer Diagnostic Devices Sales 2017-2022 (K Pcs)

Figure 38. APAC Next Generation Cancer Diagnostic Devices Revenue 2017-2022 ($ Millions)

Figure 39. Europe Next Generation Cancer Diagnostic Devices Sales 2017-2022 (K Pcs)

Figure 40. Europe Next Generation Cancer Diagnostic Devices Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue 2017-2022 ($ Millions)

Figure 43. Americas Next Generation Cancer Diagnostic Devices Sales Market Share by Country in 2021

Figure 44. Americas Next Generation Cancer Diagnostic Devices Revenue Market Share by Country in 2021

Figure 45. United States Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Next Generation Cancer Diagnostic Devices Sales Market Share by Region in 2021

Figure 50. APAC Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions in 2021

Figure 51. China Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Country in 2021

Figure 58. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Country in 2021

Figure 59. Germany Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Country in 2021

Figure 66. Egypt Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Next Generation Cancer Diagnostic Devices Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices in 2021

Figure 72. Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices

Figure 73. Industry Chain Structure of Next Generation Cancer Diagnostic Devices

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles